NEKTAR THERAPEUTICS's ticker is NKTR and the CUSIP is 640268108. A total of 165 filers reported holding NEKTAR THERAPEUTICS in Q4 2014. The put-call ratio across all filers is 0.54 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2018 | $213,000 | -61.2% | 2,000 | -96.0% | 0.03% | -71.8% |
| Q3 2015 | $549,000 | -71.5% | 50,100 | -67.5% | 0.10% | -68.4% |
| Q2 2015 | $1,929,000 | -74.7% | 154,200 | -77.7% | 0.33% | -74.3% |
| Q1 2015 | $7,617,000 | -28.8% | 692,441 | +0.3% | 1.27% | -26.6% |
| Q4 2014 | $10,705,000 | +47.0% | 690,641 | +14.5% | 1.73% | +42.2% |
| Q3 2014 | $7,284,000 | -5.7% | 603,441 | +0.2% | 1.22% | -2.8% |
| Q2 2014 | $7,724,000 | +8.2% | 602,491 | +2.3% | 1.25% | +2.1% |
| Q1 2014 | $7,138,000 | +9.3% | 588,908 | +2.3% | 1.23% | +7.9% |
| Q4 2013 | $6,533,000 | +13.9% | 575,608 | +4.8% | 1.14% | +2.1% |
| Q3 2013 | $5,738,000 | -9.5% | 549,358 | +0.1% | 1.11% | -17.7% |
| Q2 2013 | $6,342,000 | – | 549,058 | – | 1.35% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Camber Capital Management LP | 3,500,000 | $60,060,000 | 2.02% |
| ACT CAPITAL MANAGEMENT, LLC | 161,500 | $2,772,000 | 1.42% |
| Rhenman & Partners Asset Management AB | 950,000 | $16,302,000 | 1.11% |
| MAVERICK CAPITAL LTD | 5,761,073 | $98,860,000 | 0.93% |
| Birchview Capital, LP | 72,000 | $1,236,000 | 0.74% |
| Bellevue Group AG | 4,101,404 | $70,380,000 | 0.69% |
| CM Management, LLC | 50,000 | $858,000 | 0.62% |
| Duquesne Family Office | 1,000,000 | $17,160,000 | 0.42% |
| OSTERWEIS CAPITAL MANAGEMENT INC | 373,368 | $6,407,000 | 0.33% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 67,000 | $1,149,000 | 0.30% |